Previous Section
Review Articles
31. Catheter ablation of persistent and permanent atrial fibrillation: Bordeaux experience.
- Author
- Lim KT; Matsuo S; O'Neill MD; Knecht S; Arantes L; Derval N; Jais P; Hocini M; Clementy J; Haissaguerre M;
- Institution
- Hopital Cardiologique du Haut Leveque, and Universite Victor Segalen Bordeaux II, 33604 Bordeaux, Pessac, France. kangteng1973@yahoo.com
- Journal
- Expert Rev Cardiovasc Ther. 2007 Jul;5(4):655-62.
- Abstract URL
- Click here to view abstract
32. Catheter ablation as first-line therapy for patients with symptomatic atrial fibrillation.
- Author
- Chugh A;
- Institution
- University of Michigan Hospitals, Division of Cardiology, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-0311, USA. achugh@umich.edu
- Journal
- Expert Rev Cardiovasc Ther. 2007 Jul;5(4):663-72.
- Abstract URL
- Click here to view abstract
33. Post-cardiothoracic surgery atrial fibrillation: a review of preventive strategies.
- Author
- Baker WL; White CM;
- Institution
- School of Pharmacy, University of Connecticut, Hartford, CT, USA.
- Journal
- Ann Pharmacother. 2007 Apr;41(4):587-98. Epub 2007 Mar 20.
- Abstract URL
- Click here to view abstract
34. Atrial fibrillation in the elderly.
- Author
- Fang MC; Chen J; Rich MW;
- Institution
- Division of General Internal Medicine Hospitalist Group, University of California, San Francisco, CA 94143, USA. mfang@medicine.ucsf.edu
- Journal
- Am J Med. 2007 Jun;120(6):481-7.
- Abstract URL
- Click here to view abstract
35. Amiodarone for atrial fibrillation.
- Author
- Zimetbaum P;
- Institution
- Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA. pzimetba@bidmc.harvard.edu
- Journal
- N Engl J Med. 2007 Mar 1;356(9):935-41.
36. Confronting atrial fibrillation in the elderly: stroke risk stratification and emerging antithrombotic therapies.
- Author
- Strong SH; Halperin JL;
- Institution
- Kaiser Permanente, USA.
- Journal
- Geriatrics. 2007 Mar;62(3):22-7.
- Abstract URL
- Click here to view abstract
37. Modern management of atrial fibrillation.
- Author
- Watson T; Shanstila E; Lip GY;
- Institution
- University Department of Medicine, City Hospital, Birmingham.
- Journal
- Clin Med. 2007 Jan-Feb;7(1):28-34.
- Abstract URL
- Click here to view abstract
38. Vernakalant (RSD1235): a novel, atrial-selective antifibrillatory agent.
- Author
- Fedida D;
- Institution
- University of British Columbia, Department of Anesthesiology, Vancouver, British Columbia, Canada.
- Journal
- Expert Opin Investig Drugs. 2007 Apr;16(4):519-32.
- Abstract URL
- Click here to view abstract
39. Advances in surgical treatment of atrial fibrillation.
- Author
- Gillinov AM;
- Institution
- Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic, Cleveland, OH 44195, USA. gillinom@ccf.org
- Journal
- Stroke. 2007 Feb;38(2 Suppl):618-23.
- Abstract URL
- Click here to view abstract
40. Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation.
- Author
- Onalan O; Crystal E;
- Institution
- Arrhythmia Services, Division of Cardiology, Sunnybrook Health Science Centre, University of Toronto, Toronto, Canada.
- Journal
- Stroke. 2007 Feb;38(2 Suppl):624-30.
- Abstract URL
- Click here to view abstract
